STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] HOLOGIC INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Hologic Inc. Chief Financial Officer Form 4 filing details insider share activity. On 11/14/2025, the CFO reported the disposition of 1,333 shares of Hologic common stock at $74.15 per share, labeled as shares withheld to cover tax obligations related to the settlement of previously granted restricted stock units whose service-based vesting conditions were satisfied.

After this tax withholding transaction, the CFO beneficially owns 150,735 shares in total. This figure includes 41,121 restricted stock units and performance stock units whose settlement has been deferred under Hologic’s Deferred Equity Plan.

Positive
  • None.
Negative
  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Oberton Karleen Marie

(Last) (First) (Middle)
250 CAMPUS DRIVE

(Street)
MARLBOROUGH MA 01752

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
HOLOGIC INC [ HOLX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/14/2025 F 1,333(1) D $74.15 150,735(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares withheld for tax obligations in connection with the settlement of restricted stock units for which service-based vesting requirements have been satisfied.
2. Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan.
/s/ Mark W. Irving, attorney-in-fact for Ms. Oberton 11/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Hologic (HOLX) report in this Form 4?

The Form 4 reports that Hologic’s Chief Financial Officer disposed of 1,333 shares of common stock on 11/14/2025 at $74.15 per share, with the shares withheld to satisfy tax obligations tied to vested restricted stock units.

Who is the reporting person in the Hologic (HOLX) Form 4 and what is their role?

The reporting person in this Form 4 is Hologic’s Chief Financial Officer, who is identified as an Officer of the company rather than a director or 10% owner.

How many Hologic (HOLX) shares does the CFO beneficially own after the reported transaction?

Following the reported tax withholding of 1,333 shares, the Hologic CFO beneficially owns 150,735 shares of common stock.

What are the 41,121 units mentioned in the Hologic (HOLX) Form 4 footnote?

The filing explains that the total beneficial ownership includes 41,121 restricted stock units and performance stock units, with settlement deferred under Hologic’s Deferred Equity Plan.

Why were 1,333 Hologic (HOLX) shares withheld in this insider transaction?

The Form 4 states that the 1,333 shares were withheld for tax obligations in connection with the settlement of restricted stock units whose service-based vesting requirements had been met.

Is this Hologic (HOLX) Form 4 filing for one reporting person or multiple?

The filing indicates that it is a Form filed by one reporting person, specifically the company’s Chief Financial Officer.

Hologic Inc

NASDAQ:HOLX

HOLX Rankings

HOLX Latest News

HOLX Latest SEC Filings

HOLX Stock Data

16.50B
220.25M
0.86%
101.02%
1.4%
Medical Instruments & Supplies
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States
MARLBOROUGH